Polymorphisms of OCT1 and Metformin Effects in Iraqi Women with Polycystic Ovary Syndrome in Karbala City

January 2024 in “ International Journal of Biochemistry and Molecular Biology ”

Ali Hakem Kadhem

OCT1 polymorphisms metformin polycystic ovary syndrome FSH prolactin testosterone PCOS

TLDR Hormone levels can help predict metformin treatment success in women with PCOS.

The study investigates the relationship between OCT1 polymorphisms and the effects of metformin in Iraqi women with polycystic ovary syndrome (PCOS) in Karbala city. It suggests that hormonal levels of FSH, prolactin, and testosterone could serve as potential biomarkers for detecting PCOS and predicting the biomedical response to metformin treatment. This implies that monitoring these hormone levels could enhance the management and treatment outcomes for women with PCOS undergoing metformin therapy.

View this study on dx.doi.org →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Cutaneous Manifestations of Polycystic Ovary Syndrome

5 citations , March 2020 in “Current Opinion in Endocrine and Metabolic Research”

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

research Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance, and Obesity

195 citations , November 2019 in “Clinica Chimica Acta”

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Related Research

1 / 1 results

Metformin: An Old Medication of New Fashion: Evolving New Molecular Mechanisms and Clinical Implications in Polycystic Ovary Syndrome

research Metformin: An Old Medication of New Fashion: Evolving New Molecular Mechanisms and Clinical Implications in Polycystic Ovary Syndrome

200 citations , October 2009 in “European journal of endocrinology”

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.